Evidence map›Paper›PMID 31201892›Full record

ArticleInternational journal of radiation oncology, biology, physics2019

Markerless Pancreatic Tumor Target Localization Enabled By Deep Learning.

Wei Zhao, Liyue Shen, Bin Han, Yong Yang, Kai Cheng, Diego A S Toesca, Albert C Koong, Daniel T Chang, Lei Xing

Open access · bronzeAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
13.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Artificial intelligence for treatment delivery: image-guided radiotherapy.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Wei ZhaoDepartment of Radiation Oncology, Stanford University, Stanford, California.
Liyue ShenDepartment of Radiation Oncology, Stanford University, Stanford, California.
Bin HanDepartment of Radiation Oncology, Stanford University, Stanford, California.
Yong YangDepartment of Radiation Oncology, Stanford University, Stanford, California.
Kai ChengDepartment of Radiation Oncology, Stanford University, Stanford, California.
Diego A S ToescaDepartment of Radiation Oncology, Stanford University, Stanford, California.
Albert C KoongDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Daniel T ChangDepartment of Radiation Oncology, Stanford University, Stanford, California.
Lei XingDepartment of Radiation Oncology, Stanford University, Stanford, California. Electronic address: lei@stanford.edu.
Stanford University · USThe University of Texas MD Anderson Cancer Center · US

Funding

Dual Modality X-ray Luminescence CT for in vivo Cancer ImagingR01CA227713 · NCI · STANFORD UNIVERSITY · PI XING, LEI · 2019 to 2023
$2.9M
Radioluminescence dosimetry solution for precision radiation therapyR01CA223667 · NCI · STANFORD UNIVERSITY · PI XING, LEI · 2018 to 2022
$2.4M
DASSIM-RT and Compressed Sensing-Based Inverse PlanningR01CA176553 · NCI · STANFORD UNIVERSITY · PI XING, LEI · 2014 to 2018
$2.4M
NCI NIH HHS R01 CA176553NCI NIH HHS R01 CA223667NCI NIH HHS R01 CA227713
6 · The paper itself

Abstract

purposeDeep learning is an emerging technique that allows us to capture imaging information beyond the visually recognizable level of a human being. Because of the anatomic characteristics and location, on-board target verification for radiation delivery to pancreatic tumors is a challenging task. Our goal was to use a deep neural network to localize the pancreatic tumor target on kV x-ray images acquired using an on-board imager for image guided radiation therapy. METHODS AND MATERIALS: The network is set up in such a way that the input is either a digitally reconstructed radiograph image or a monoscopic x-ray projection image acquired by the on-board imager from a given direction, and the output is the location of the planning target volume in the projection image. To produce a sufficient number of training x-ray images reflecting the vast number of possible clinical scenarios of anatomy distribution, a series of changes were introduced to the planning computed tomography images, including deformation, rotation, and translation, to simulate inter- and intrafractional variations. After model training, the accuracy of the model was evaluated by retrospectively studying patients who underwent pancreatic cancer radiation therapy. Statistical analysis using mean absolute differences (MADs) and Lin's concordance correlation coefficient were used to assess the accuracy of the predicted target positions.

resultsMADs between the model-predicted and the actual positions were found to be less than 2.60 mm in anteroposterior, lateral, and oblique directions for both axes in the detector plane. For comparison studies with and without fiducials, MADs are less than 2.49 mm. For all cases, Lin's concordance correlation coefficients between the predicted and actual positions were found to be better than 93%, demonstrating the success of the proposed deep learning for image guided radiation therapy.

conclusionsWe demonstrated that markerless pancreatic tumor target localization is achievable with high accuracy by using a deep learning technique approach.

Indexed as

Deep LearningDatasets as TopicFiducial MarkersHumansImage Processing, Computer-AssistedNeural Networks, ComputerOrgan MotionPancreasPancreatic NeoplasmsRadiographyRadiotherapy, Image-Guided

Identifiers

PMID31201892
PMCPMC6732032
OpenAlexW2951743624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.